Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Gene Therapy00:59

Gene Therapy

4.4K
4.4K
Unrenewable Cells00:50

Unrenewable Cells

2.1K
In humans, the photoreceptor cells of the eye and sensory hair cells of the ear lack stem cells. These cells are thus unrenewable and cannot be replaced when they are damaged or destroyed.
Photoreceptors
The retina is composed of several layers and contains specialized cells called photoreceptors. The photoreceptors (rods and cones) change their membrane potential when stimulated by light energy. There are two types of photoreceptors—rods and cones—which differ in the shape of...
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bi-allelic missense variants in human GPN2 result in Perrault syndrome.

American journal of human genetics·2026
Same author

Clinically relevant AAV8- <i>PEX1</i> gene therapy preserves retinal integrity and function long-term in a murine model of Zellweger spectrum disorder.

bioRxiv : the preprint server for biology·2026
Same author

Cisplatin Differentially Damages Mammalian Vestibular End Organs.

Ear and hearing·2025
Same author

Cross-Sectional and Longitudinal Analyses of the Association Between Statin Use and Age-Related Hearing Loss.

Drugs & aging·2025
Same author

International expert consensus on gene therapy for hereditary hearing loss: Based on clinical trials.

Med (New York, N.Y.)·2025
Same author

Lower, more frequent cisplatin dosing minimizes hearing loss in head and neck cancer.

JCI insight·2025

Related Experiment Video

Updated: Apr 25, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

10.0K

Gene therapy for sensorineural hearing loss.

Wade W Chien1, Elyssa L Monzack, Devin S McDougald

  • 11Section on Sensory Cell Biology, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland, USA; and 2Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.

Ear and Hearing
|August 29, 2014
PubMed
Summary
This summary is machine-generated.

Gene therapy offers a promising approach for inherited hearing loss by correcting genetic defects and potentially regenerating cochlear hair cells. This review explores gene therapy

More Related Videos

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

16.3K
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

20.5K

Related Experiment Videos

Last Updated: Apr 25, 2026

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
03:52

Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse

Published on: March 2, 2018

10.0K
Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane
07:32

Surgical Method for Virally Mediated Gene Delivery to the Mouse Inner Ear through the Round Window Membrane

Published on: March 16, 2015

16.3K
Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss
09:44

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

20.5K

Area of Science:

  • Otolaryngology
  • Genetics
  • Regenerative Medicine

Background:

  • Hearing loss is a prevalent global disability with significant genetic underpinnings.
  • Current treatments for hearing loss are limited, highlighting the need for novel therapeutic strategies.
  • Gene therapy presents a potential avenue for addressing the genetic causes of hearing loss.

Purpose of the Study:

  • To review the potential applications of gene therapy for treating hearing loss.
  • To examine the challenges and opportunities associated with cochlear gene therapy.
  • To summarize recent advancements in gene therapy for hearing loss models.

Main Methods:

  • Review of current literature on gene therapy for inherited disorders.
  • Analysis of studies applying gene therapy to animal models of hearing loss.
  • Examination of gene therapy's role in hair cell regeneration.

Main Results:

  • Gene therapy can potentially restore hearing by addressing genetic mutations.
  • Gene therapy may induce hair cell regeneration in the cochlea.
  • Recent studies show promise in animal models, but clinical translation requires further research.

Conclusions:

  • Gene therapy holds significant promise for treating genetic hearing loss.
  • Overcoming challenges in cochlear delivery and safety is crucial for clinical success.
  • Further research in animal models is essential to advance gene therapy for hearing restoration.